Tirzepatide for maintenance of bodyweight reduction in people with obesity in the USA (SURMOUNT-MAINTAIN): a multicentre, double-blind, randomised, placebo-controlled trial - thelancet.com/journals/lance…
English
Prof. Wasim Hanif
8.9K posts
Prof. Wasim Hanif
@docwas
Professor of Diabetes at University Hospital Birmingham by trade, Indian by birth, British by work, Cricketer by choice and Human by Right.....
Birmingham UK Katılım Ağustos 2009
705 Takip Edilen5.2K Takipçiler
Pasteurized Akkermansia muciniphila MucT for weight loss maintenance in people with overweight and obesity: a controlled randomized trial nature.com/articles/s4159…
English
Kamlesh account has been hacked and people are getting DM to Vote. PLEASE DO NOT CLICK as your account will be hacked as well @AskDrShashank @LDC_tweets @dramitaol @banshisaboo @purvi_chawla @docanoopmisra @drmohanv @SouthAsianHF @AliRacaniere @AliaGilani @m_alikaramat
English
NICE continues to make Evidence Based recommendations now it is down to ICB and clinicians to make sure that these benefits reach all patients @DrDerekConnolly
NICE@NICEComms
New recommendation: Semaglutide (Wegovy) can now be prescribed to help protect the heart, not just to manage weight: nice.org.uk/guidance/ta115… It's for adults who've already had a heart attack, stroke, or cardiovascular event and have a BMI of 27 or above.
English
No increase risk of NAION with GLP-1. Pooled data from around 97,000 patients-from randomised placebo-controlled trials with semaglutide and liraglutide do not show an increased incidence of NAION in participants receiving GLP-1RA treatment. bjo.bmj.com/content/early/…
English
Very disheartening that an excellent medication that helps to save and change lives for millions in India with diabetes and obesity is being made spuriously. Risking lives. Authorities please act @PMOIndia @DrJitendraSingh @JPNadda
English
Oral glucose absorption is enhanced in early metabolic dysfunction-associated steatotic liver disease | Link between Gut Liver axis in the pathogenesis on MASLD link.springer.com/article/10.100…
English
Once-weekly semaglutide versus placebo in patients with alcohol use disorder and comorbid obesity: a randomised, double-blind, placebo-controlled trial - thelancet.com/journals/lance…
English
English
Delighted to take Vice-chair role @DiabetesUK
Privileged to be the first South Asian female to do so. Looking forward to the next 2 years focusing on addressing health & ethnic inequalities …my passion for the last 25 years 🙏🏼❤️
English
@parthaskar @sasbanerjee @PaedED @jsbamrah @NHSE_WTE @drpratikc @Rezaidi @DrSelvarajah @NHSEngland @RaoMala When people ask me “Aren’t you scared? Scared? I once packed my whole life into two 23 KG bags and moved to a country where I didn’t know anyone…our story #IMG
English
I will never be not bemused by how many national leaders & organisations lost their collective voice and spine when it came to International Medical Graduates.
Especially the IMGs themselves in positions of authority
Par for the course however when they adopt a similar attitude
English
Our paper led by @samiul_m Effect of Behavioral Sleep Interventions on Measures of Obesity, Dietary Intake and Physical Activity in Adults With Poor Sleep Health: A Systematic Review, Meta‐Analysis and Meta‐Regression Analysis - onlinelibrary.wiley.com/doi/10.1111/ob…
English
@parthaskar @TheLancetEndo @ShivaniM_KC @GoggleDocs @SGPModalityAWC @geraldinegallen @PNewlandJones @HannahBeba @pcdosociety @DrSelvarajah @ctmarshallceo There are some publications that are transformative for patients care…..congratulations @WilmotEmma and colleagues for this excellent study
English
An IMPORTANT trial (RCT) via @TheLancetEndo
"FREEDM2"
A landmark UK study of the use of #CGM in people living with #T2Diabetes
TL:DR:
In adults with type 2 diabetes on basal insulin plus modern therapies, real-time CGM improved
glycaemic control versus SMBG during
English
Prof. Wasim Hanif retweetledi
Prof. Wasim Hanif retweetledi
Fab presentation thank you @docwas @AliRacaniere
Prof Kamlesh Khunti@kamleshkhunti
Thank you @DiabetesUK for dedicating the conference on inequalities 👏👏👏 Next session continues the thread -closing the gap on inequalities With good friends @AliRacaniere @docwas Jonathan Valabhji & Michael Gibbs #DUKAPC2026
English
Prof. Wasim Hanif retweetledi
Thank you @DiabetesUK for dedicating the conference on inequalities 👏👏👏
Next session continues the thread -closing the gap on inequalities
With good friends @AliRacaniere @docwas Jonathan Valabhji & Michael Gibbs
#DUKAPC2026
English
Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity Treatment. There is a lot of interest among patients about this drug. It makes you loose about 11% body weight and could be cheaper then some of the current medication nejm.org/doi/full/10.10…
English
Interrelationship Between Baseline HbA1c, SGLT‐2 Inhibitor Use and Risk of Diabetic Ketoacidosis in Adults With Type 2 Diabetes: very pertinent study by @scelee1 @kamleshkunti …ubs.pericles-prod.literatumonline.com/doi/10.1111/do…
English
The expanding benefits of GLP-1 medicines: Cell Reports Medicine cell.com/cell-reports-m…
English
Genetic predictors of GLP1 receptor agonist weight loss and side effects nature.com/articles/s4158…
English